Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Total 13F shares
-
39,953,370
-
Share change
-
-14,392,304
-
Total reported value
-
$164,926,021
-
Put/Call ratio
-
195%
-
Price per share
-
$4.12
-
Number of holders
-
112
-
Value change
-
-$163,393,442
-
Number of buys
-
58
-
Number of sells
-
59
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q1 2022
As of 31 Mar 2022,
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,953,370 shares.
The largest 10 holders included
Redmile Group, LLC, Frazier Life Sciences Management, L.P., BlackRock Inc., Versant Venture Management, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, Palo Alto Investors LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.